language_icon
EN
HI

Beta Drugs Share price

BETA

1590.4

16.30 (-1.01%)
Last updated on 13 Jan, 2026 | 15:31 IST
alert_iconwatchlist_icon
BUYSELL
Today's High

1624.10

Today's Low

1563.10

52 Week Low

1429.52

52 Week High

2000.00

alert_iconThe current prices are delayed, login to your account for live prices

Beta Drugs Chart

Beta Drugs Share Key Metrics

Volume
2135.00
Market Cap
1605.44 CR
LTQ@LTP
15@1590.40
ATP
1598.14
Var Margin
12.5 %
Circuit Range
1285.4-1928
Delivery %
53.82 %
Value
34.12 L
ASM/GSM
No
Market Lot
1

Summary

At 13 Jan, 2026 | 15:31, Beta Drugs share price stands at ₹1590.4, showing a 16.30% -1.01 for the day. The stock’s intraday movement has stayed between ₹1563.10 and ₹1624.10, while on a 52-week basis it has fluctuated from ₹1429.52 to ₹2000.00.
In terms of trading activity, Beta Drugs has recorded a volume of 2135 shares, with a market capitalisation of ₹10094553. The stock’s Average Traded Price (ATP) stands at ₹159814, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 15,159040. The stock operates within a circuit range of ₹1285.4-1928, with a Value of ₹34.12 L. The Delivery Percentage for the day is 53.82%. Additionally, Beta Drugs currently falls under the No framework, and trades with a market lot size of 1.

Beta Drugs Fundamentals

View More
P/E Ratio

38.24

P/B Ratio

8.23

Div. Yield

0

Sector P/E

69.86

Sector P/B

0.96

Sec. Div. Yield

0.57

No Data Found

Beta Drugs Futures & Options

Data Not Found

Beta Drugs Shareholding Pattern

View More
  • 2019-20
  • 2023-24
  • 2024-25
  • 2025-26
  • 2022-23
  • 2021-22
  • 2020-21
  • 2018-19
Total Promoters
Segment
Percent

Total Promoters

66.73%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0.9%

Domestic Institutional Investors

0.28%

Retail

32.08%

Others

0.01%

Total Promoters
MAR '25
66.73%
JUN '25
66.73%
SEP '25
66.73%

Beta Drugs Corporate Actions

DateAgenda
2026-01-09Others

Beta Drugs News

Beta Drugs raises Rs 117 crore from HealthQuad

Nov 28 2024 05:41:53
Read More

About Beta Drugs

NSE : 759842  
BSE : 0  
ISIN : INE351Y01019  

The Company was incorporated as ?Beta Drugs Private limited? at Himachal Pradesh as a private limited company under the provisions of the Companies Act 1956 vide Certificate of Incorporation dated September 21 2005 bearing Corporate Identification Number U24230HP2005PTC28969 issued by Registrar of Companies Punjab Himachal Pradesh and Chandigarh. Subsequently the Company was converted in to public limited company pursuant to Shareholders Resolution passed at the Extra-Ordinary General Meeting of the Company held on July 24 2017 and the name of the Company was changed to ?Beta Drugs Limited? pursuant to issuance of fresh Certificate of Incorporation consequent upon conversion of Company from Private to Public Limited dated August 11 2017 issued by the Registrar of Companies Himachal Pradesh. The Corporate Identification Number of the Company is U24230HP2005PLC028969.KEY EVENTS AND MILESTONES IN THE HISTORY OF THE COMPANY2005 -Incorporation of the Company as Beta Drugs Private Limited2014 -Vijay Kumar Batra existing promoter took over the Company2015-ISO: 9001:2008 Certification for manufacturing and supply of Pharmaceutical products such as Oncology  Sterile Injections and Lyophilized Injections and Oncology solid oral medication tablets and capsules-Certificate of Good Manufacturing Practice from Health and Family Welfare Department Himachal Pradesh2016-Certificate of Good Manufacturing Practice from Republic of Kenya2017 -Conversion of Company into Public Limited Company

Read More

Beta Drugs Management

NamePosition
Mr. Rahul Batra Chairperson & Managing Director
Mr. Varun Batra Joint Managing Director
View More

Beta Drugs FAQs

The Buying Price of Beta Drugs share is 1590.4 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Beta Drugs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Beta Drugs, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Beta Drugs shares is 38.24. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Beta Drugs shares is 8.23. Useful to assess the stock's value relative to its book value.

To assess Beta Drugs’s valuation compare Sector P/E, P/B which are 69.86 & 0.96 with sector averages, along with growth rates and financial metrics.

The Market Cap of Beta Drugs is 1605.44 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Beta Drugs share price is 2000.00 & 1429.52. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Beta Drugs belongs to the Healthcare sector.